BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor
- Resource Type
- Article
- Authors
- Fiskus, Warren; Piel, Jessica; Collins, Mike; Hentemann, Murphy; Cuglievan, Branko; Mill, Christopher P.; Birdwell, Christine E.; Das, Kaberi; Davis, John A.; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Kadia, Tapan M.; Daver, Naval; Sasaki, Koji; Takahashi, Koichi; Hammond, Danielle; Reville, Patrick K.; Wang, Jian; Loghavi, Sanam; Sen, Rwik; Ruan, Xinjia; Su, Xiaoping; Flores, Lauren B.; DiNardo, Courtney D.; Bhalla, Kapil N.
- Source
- In Blood 16 May 2024 143(20):2059-2072
- Subject
- Myeloid Neoplasia
- Language
- ISSN
- 0006-4971